A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein

Pang, W; Lu, Y; Zhao, YB; Shen, F; Fan, CF; Wang, Q; He, WQ; He, XY; Li, ZK; Chen, TT; Yang, CX; Li, YZ; Xiao, SX; Zhao, ZJ; Huang, XS; Luo, RH; Yang, LM; Zhang, M; Dong, XQ; Li, MH; Feng, XL; Zhou, QC; Qu, W; Jiang, SB; Ouyang, SY; Zheng, YT

Zheng, YT (通讯作者),Chinese Acad Sci, Kunming Inst Zool, KIZ CUHK Joint Lab Bioresources & Mol Res Common, Key Lab Anim Models & Human Dis Mech,Key Lab Bioa, Kunming, Yunnan, Peoples R China.;Zheng, YT (通讯作者),Univ Chinese Acad Sci, Beijing, Peoples R China.;Ouyang, SY (通讯作者),Fujian Normal Univ, Coll Life Sci, Minist Educ,Biomed Res Ctr South China,Key Lab Op, Key Lab Innate Immune Biol Fujian Prov,Prov Univ, Fuzhou, Fujian, Peoples R China.;Jiang, SB (通讯作者),Fudan Univ, Sch Basic Med Sci, Shanghai I

CELL RESEARCH, 2022; 32 (12): 1068

Abstract

The emerging SARS-CoV-2 variants, commonly with many mutations in S1 subunit of spike (S) protein are weakening the efficacy of the current vaccines a......

Full Text Link